Prague Opens New National Oncology Centre in Motol

Prague’s new National Oncology Centre opened on Wednesday. The facility combines diagnostics, treatment, research and prevention and is intended to give patients faster access to appropriate cancer treatment.

Czech Prime Minister Andrej Babiš and Health Minister Adam Vojtěch officially opened the National Oncology Centre of Motol University Hospital and Na Homolce Hospital on Wednesday, 9 September 2026. Once fully operational, it is expected to increase oncology care capacity by up to 40 per cent.

Construction of the centre cost almost CZK 5 billion. According to the government, this makes it one of the most significant investments in the Czech healthcare system in recent years.

Foto: Vláda České republiky

The new facility aims to shorten and simplify the process from the initial suspicion of cancer through diagnosis to the start of appropriate treatment. Diagnostic, therapeutic, preventive and supportive services will therefore be brought together at a single location.

At the same time, the centre draws on the medical infrastructure and specialist staff of Motol University Hospital and Na Homolce Hospital. According to the Ministry of Health, the concept is based on leading oncology centres in Europe.

Foto: Vláda České republiky

“Today, we are opening a centre that combines cutting-edge medicine, research and specialist care so that patients can receive the right diagnosis and treatment more quickly,” Prime Minister Babiš said at the opening. He added that the centre represented an investment both in public health and in the future of the Czech healthcare system.

Health Minister Vojtěch emphasised that the facility was intended to provide care meeting the highest European standards. He said the investment would translate directly into faster diagnoses and an earlier start to appropriate treatment.

Foto: Vláda České republiky

The National Oncology Centre is beginning operations gradually. Some specialist departments are already treating their first patients, while other sections are expected to follow in the coming months. Once fully operational, the centre is expected to become one of the most important cancer medicine facilities in Central Europe.